Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients. [electronic resource]
- In vivo (Athens, Greece) 01 2017
- 125-131 p. digital
Publication Type: Journal Article
1791-7549
10.21873/invivo.11035 doi
Biomarkers--analysis CCR5 Receptor Antagonists--pharmacology Carotid Intima-Media Thickness Coinfection--drug therapy Cyclohexanes--therapeutic use Female HIV Infections--drug therapy HIV-1--drug effects Hepacivirus--drug effects Hepatitis C, Chronic--drug therapy Humans Liver Cirrhosis--chemically induced Male Maraviroc Middle Aged Pilot Projects Polymerase Chain Reaction Prospective Studies Triazoles--therapeutic use Ultrasonography, Doppler, Color